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Background: Methylmalonyl-CoA mutase (MCM) is an adenosylcobalamin-dependent enzyme that catalyses the
interconversion of (2R)-methylmalonyl-CoA to succinyl-CoA. In humans, a deficit in activity of MCM, due to an
impairment of intracellular formation of adenosylcobalamin and methylcobalamin results in a wide spectrum of
clinical manifestations ranging from moderate to fatal. Consequently, MCM is the subject of abundant literature.
However, there is a lack of consensus on the reliable method to monitor its activity. This metabolic pathway is
highly solicited in ruminants because it is essential for the utilization of propionate formed during ruminal
fermentation. In lactating dairy cows, propionate is the major substrate for glucose formation. In present study, a
reversed-phase high performance liquid chromatography (RP-HPLC) was optimized and validated to evaluate MCM
activity in bovine liver. The major aim of the study was to describe the conditions to optimize reproducibility of the
method and to determine stability of the enzyme and its product during storage and processing of samples.
Results: Specificity of the method was good, as there was no interfering peak from liver extract at the retention times
corresponding to methylmalonyl-CoA or succinyl-CoA. Repeatability of the method was improved as compared to
previous RP-HPLC published data. Using 66 μg of protein, intra-assay coefficient of variation (CV) of specific activities,
ranged from 0.90 to 8.05% and the CV inter-day was 7.40%. Storage and processing conditions (frozen homogenate of
fresh tissue vs. fresh homogenate of tissue snapped in liquid nitrogen) did not alter the enzyme activity. The analyte was
also stable in liver crude extract for three frozen/thawed cycles when stored at −20°C and thawed to room temperature.
Conclusions: The improved method provides a way for studying the effects of stages of lactation, diet composition, and
physiology in cattle on MCM activity over long periods of time, such as a complete lactation period. Interestingly, this
sensitive and accurate method could benefit the study of the cobalamin status in experimental studies and clinical cases.
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Methylmalonyl-CoA mutase (MCM) is a bacterial and
vertebrate adenosylcobalamin-dependent enzyme that
catalyses the interconversion of (2R)-methylmalonyl-CoA to
succinyl-CoA [1]. In some bacteria, such as Propionibacter-
ium shermanii, MCM is important for the fermentation of
pyruvate to propionate [2]; linking the production of propi-
onate from succinate in a reverse metabolic pathway [3]. In* Correspondence: bouattus@gmail.com
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metabolism of methylmalonyl-CoA [4]. In humans, a def-
icit in activity ofMCM, due to an impairment of intracellu-
lar formation of adenosylcobalamin and methylcobalamin,
respective cofactors for the MCM and methionine syn-
thase, results in a wide spectrum of clinical manifestations
(reviewed by Carrillo-Carrasco [5]). Methylmalonyl-CoA is
produced by catabolism of odd-chain fatty acids and some
amino acids such as valine, isoleucine and methionine.
This metabolic pathway has a high flux level in ruminants
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ruminants, MCM plays a major role in energy produc-
tion via succinyl-CoA, an essential step for its entry in
Krebs cycle [7]. In dairy cows, increasing affinity of MCM
for its cofactor increases gluconeogenesis [8]. Owing to its
importance, determining the activity of MCM is the sub-
ject of abundant literature [8-28]. Several methods based
on the quantification of succinyl-CoA produced from
methylmalonyl-CoA, have been used to study MCM activ-
ity. The radioassay based on the permanganate oxidation
of DL[CH3-14C]methylmalonyl-coenzyme A is the most
commonly used. Unfortunately, sensitivity and reproduci-
bility of the radiometric method are low [7,29]. To over-
come these problems, a spectrophotometric assay has
been developed to allow a more accurate estimation of
MCM kinetic parameters [7,8] however, spectrophotomet-
ric methods are more appropriate for studying the activity
of purified enzyme. An electrophoretic separation method
for MCM activity using surfactant for separation was
also proposed [30]. However, the injection of high-con
centration surfactant into the electrophoretic capillary
may decrease both the separation efficiency and the
reproducibility [31]. Other chromatographic techniques
were also used to measure MCM activity [19,29]. How-
ever the existing liquid chromatographic methods suffer
from a lack of validation data to support their routine
use. In the present work, a RP-HPLC method was opti-
mized and validated to measure MCM activity in bovine
liver. The analyte stability in regard to tissue storage
conditions was assessed. The performance of the method
was evaluated by measuring holo and total MCM activity
in the liver of six cows. Coefficients of variation (CV) and
standard deviation of repeated analyses, as well as system
suitability parameters were determined. The major aim of
the study was to describe the conditions to optimize
reproducibility of the method.
Methods
Reagents and chemicals
Methylmalonyl-coenzyme A (lithium salt), succinyl-coen
zyme A (sodium salt), 5′-deoxyadenosylcobalamin (Ado
Cbl), phosphoric acid, trichloroacetic acid (TCA), tris-base,
sodium phosphate monobasic and sodium phosphate di-
basic were purchased from Sigma-Aldrich (Canada Ltd,
Oakville, ON, CANADA). HPLC-gradient grade methanol
was obtained from Fisher (Fair Lawn, NJ, USA). One
mL-TB (Tuberculin) syringes were purchased from BD
(Franklin Lakes, NJ, USA), PVDF (polyvinylidene difluo-
ride) syringe filters (units) 0.45 μm were manufactured
by National Scientific Company (Rockwood, TN, USA)
and 1.5 mL boil-proof microtubes were distributed by
Ultident Scientific (Montréal, QC, Canada). Filter sheets
0.2 μm were manufactured products of Pall Corporation
(Ann Arbor, MI, USA).Sample preparation
Bovine liver was purchased from a slaughterhouse (Viande
Giroux, East Angus, QC, Canada), collected immediately
after slaughter and transported on ice to the laboratory
within 50 minutes. Upon arrival at the laboratory, a por-
tion of the liver was homogenized on ice in 4.5 volumes
(w/v) of cold distilled water. The homogenates were cen-
trifuged at 750 g for 10 minutes at 4°C. The supernatants
were then aliquoted (1 mL) and stored in microcentrifuge
tubes at –80°C. The remaining hepatic tissue was cut in
pieces, immediately frozen into liquid nitrogen and stored
at −80°C until use. On the day of analysis, a small volume
(~30 μL) was used to measure protein concentration by
the method of Bradford using bovine serum albumin as
standard (Bio-Rad protein assay kit, Bio-Rad Laboratories
(Canada) Ltd, Mississauga ON, Canada). Then, the remain-
der of the homogenate was diluted with distilled water to
obtain the chosen protein concentration for the assay.
Hepatic tissue was also obtained by liver biopsy performed
on 6 lactating dairy cows, 64 ± 3 days after calving, under
local anesthesia and ultrasound guidance to minimize the
hemorrhagic risks as described by Graulet et al. [8]. The
procedure was approved by the Institutional Committee
on Animal Care of the Dairy and Swine Research and
Development Centre, Agriculture and Agri-Food Canada,
Sherbrooke, QC, Canada. Tissues were immediately frozen
into liquid nitrogen and stored at −80°C until use. Ho-
mogenates from frozen tissues (biopsies from dairy cows
and tissue from the slaughterhouse) were prepared as
described above.
Preparation of standards
A stock solution of methylmalonyl-CoA (1 mM) was
prepared in 300 mM of tris-phosphate buffer, pH 7.5;
this solution was aliquoted and kept at –30°C. Thus, cali-
bration solutions of methylmalonyl-CoA could be prepared
by diluting the stock solution in 100 mmol/L phosphate
buffer, pH 4.0. The succinyl-CoA calibration solutions
(stock, 500 μM) were prepared in 200 mmol/L phosphoric
acid, pH 1.8, aliquoted and stored at –30°C. A solution of
AdoCbl (1 mM) for the determination of total enzyme ac-
tivity was also prepared in distilled water, protected against
light inactivation and stored at –30°C.
Liquid chromatography
The HPLC analyses were carried out on an Agilent tech-
nology system consisting of two proStar 210 pumps, 320
UV detector and 420 AutoSampler. The Agilent Poroshell
120 EC-C18, 2.7 μm, 3.0 mm × 100 mm threaded column
was heated at 40°C with a HPLC column heater Croco-cil®.
The assay reaction mixture for total MCM activity con-
tained, in a total volume of 150 μL, 16 to 333 μg of liver
homogenate protein (60 μL), 30 μL of AdoCbl (1 mM),
and 60 μL of methylmalonyl-CoA (1 mM). The liver
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at 37°C before initiating the enzyme reaction by adding
methylmalonyl-CoA. The tubes were again incubated at
37°C for 0 to 30 minutes and the reaction was stopped by
adding 50 mL of trichloroacetic acid (TCA; 100 g/L). The
tubes were centrifuged at 13 000 g for 1 min. The super-
natant was collected and filtered in amber glass vials
through a 0.45 μm syringe-operated filter units. A volume
of 20 μL of sample was injected in the HPLC system.
Blanks were included in every run.
The reverse phase column was equilibrated with 56%
solvent A (100 mM acetic acid in 100 mM of sodium
phosphate buffer, pH 7.0) and 44% solvent B (18% v/v
methanol in solvent A). The method consisted in a linear
methanol gradient: 0 – 3 min (44% solvent B); 3 – 9 min
(44 – 75%); 9 – 12 min (75 – 100%); 12 – 17 min (100 –
44%); and 17 – 35 min (44%) with a flow rate of 0.2 mL/
min. The solvent A was filtered through 0.2 μm mem-
brane. The compounds were detected at 254 nm.Validation of the method
Method validation was performed according to guide-
lines set by the United States Food and Drug Adminis-
tration (FDA) for bioanalytical method validation [32].
Hence, linearity, specificity, low limit of quantitation
(LLOQ), recovery, intra- and inter-day accuracy and pre-
cision, and stability of the analyte during sample storage
and processing procedures were determined.Linearity and sensitivity
The lowest standard on the calibration curve has been
determined by testing a range from 0.48 to 500 μM. Each
concentration was prepared in duplicate and the test was
repeated once. Calibration curves were built by plotting
peak areas versus concentrations of methylmalonyl-CoA
or succinyl-CoA, and the regression equations were calcu-
lated. Low limits of detection (LOD) were determined
when electropherograms produced peaks with a signal-to-
noise ratio (S/N) of 3 at 254 nm wavelength. The LLOQ
were determined based on the S/N (> 5), CV (< 20%) and
accuracy (> 80%). Linearity of the reaction according to
enzyme concentrations obtained by different dilutions of
the liver extract homogenates was also determined. The
amounts of protein tested were: 16, 26, 33, 52, 66, 83, 104,
166, 208 and 333 μg. The linearity of the enzyme reaction
versus incubation time (0, 5, 10, 15, 20, 25, 30 and 40 min)
was also measured.Specificity
The specificity of the method for dilutions of methyl
malonyl-CoA and succinyl-CoA was tested on samples
spiked and not spiked with known standards.Method precision and recovery
The precision of the instruments was checked using
samples injected repeatedly (n = 45). Forty-five replicates
of homogenates providing 66 μg of protein were assayed
over nine days. The intra- and inter-assay precisions were
determined using the CV. Separate runs of three levels of
standards (Low = 7.8 μM; Middle = 62.5 μM and High =
500 μM) were made. The accuracy (%) of the method was
expressed by [(Measured concentration)/(Nominal con-
centration)] × 100.
The recovery of succinyl-CoA was studied by addition
of a known amount of standard (75 μM) to prequantified
samples after stopping the reaction. Briefly, a volume of
50 μL of TCA was added to the reaction mixture to stop
the reaction and after centrifugation, 170 μL of the su-
pernatant was collected. This volume was completed to
200 μL by adding 30 μL of standard (stock, 500 μM).
Recovery was performed by comparing the analytical
results for extracted samples at the three concentrations
tested (33, 66 and 166 μg of protein) with standards that
represent 100% recovery. Recovery (%) = [(Measured con-
centration in spiked sample – Measured concentration in
non-spiked sample)/Standard concentration] × 100.
Stability study
The amounts of succinyl-CoA formed using frozen
extracts prepared from fresh liver or extracts prepared
from tissue snapped in liquid nitrogen were compared
and the CV between the two modes of preparation was
calculated. The percentages of difference between days
of runs were also calculated as follow:% difference dayn
vs dayn+1 = [(Concentration on dayn- Concentration on
dayn+1)/Concentration on dayn)] × 100. These runs in-
cluded two vials of a known concentration of the stand-
ard succinyl-CoA (75 μM) and two vials of standards
(succinyl-CoA +methylmalonyl-CoA, 125 μM each) mixed
to check the reliability of the method. The stability of
standard and sample solutions when re-injected after being
left at room temperature for more than 24 hours was
evaluated to detect if the time spent in the autosampler
affected the measurements.
Pharmacokinetic study
As component of ongoing studies to validate the HPLC
method for the evaluation of MCM activity in bovine
liver extract, pharmacokinetics of MCM was studied.
The kinetics of MCM was established by testing increas-
ing concentrations of substrate, methylmalonyl-CoA: 6.25,
12.5, 25, 50, 100, 200 and 400 μM. The initial amount of
protein (enzyme) and the time of incubation were 66 μg
and 30 min respectively.
Holomutase and total specific activities were measured
in liver tissue obtained by biopsy from six lactating dairy
cows. Testing increasing concentrations of protein allowed










7.81 6.74 10.38 86.33
15.62 15.35 1.22 98.28
31.25 30.72 1.20 98.32
62.5 63.98 1.65 102.37
125 125.71 0.40 100.57
250 249.47 0.15 99.79








15.62 15.33 1.34 98.12
31.25 31.20 0.10 99.85
62.5 63.65 1.28 101.83
125 125.55 0.31 100.44
250 249.47 0.15 99.79
500 495.82 0.59 99.16
The calculated concentrations are compared to nominal concentrations and
the coefficients of variation (CV%) are presented. Solvent A of the mobile
phase contained 0.1 M sodium phosphate buffer (pH 7) with 100 mM of acetic
acid. Solvent B consisted of 18% methanol in solvent A. The column
temperature was 40°C.
Figure 1 Electropherograms of a solution of methylmalonyl-CoA and
phosphate buffer (pH 7) containing 100 mM of acetic acid, as solvent A of
solvent B. The column temperature was 40°C.
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obtain reproducible results from these homogenates.
Data analysis
Means, standard errors and CV were calculated using
Excel software. In figures, values are means, with their




The lowest concentrations of succinyl-CoA and methyl
malonyl-CoA measured with precision were respectively
6.74 μM and 15.33 μM (Table 1). However the LOD were
about 1 μM for succinyl-CoA and 2 μM for methyl
malonyl-CoA. Figure 1 shows the typical chromatogram of
a mixture of methylmalonyl-CoA (RT = 10.4 min) and
succinyl-CoA (RT = 12.3 min). Calibration curves were
plotted from LLOQ of each standard to 500 μM. The CV
for the seven calibration standard points of succinyl-CoA
ranged from 0.15 to 10.38% with accuracy varying from 86
to 102.37% (Table 1). The curve of methylmalonyl-CoA
(Additional file 1: Figure S1) had six points with CV of
0.10 to 1.34% and accuracy varying from 98.12 to 101.83%
(Table 1).
System suitability parameters such as theoretical plate
number, relative retention time, tailing, selectivity and cap-
acity factors between methylmalonyl-CoA and succinyl-
CoA presented in Additional file 2: Table S1 were checkedsuccinyl-CoA. Chromatograms were obtained using 0.1 M sodium
the mobile phase, and 18% of methanol in solvent A being the
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formance. The resolution between methylmalonyl-CoA
and succinyl-CoA is not less than 2 and tailing factor for
each peak is not more than 2. The plate count is also
greater than 2000.
The concentration (y) of succinyl-CoA formed was evalu-
ated using the calibration curve (y = 28564x + 35388; R2 =
0.9999), where peak area is x. The conditions under which
the conversion of methylmalonyl-CoA into succinyl-CoA
was linear with respect to incubation time and the amount
of liver crude extract used were studied. The formation of
succinyl-CoA increased linearly when the amounts of pro-
tein in the assay increased from 16 to 66 μg (Figure 2A).
The rate of the formation of succinyl-CoA slowed down
from 66 to 208 μg and even declined when a greater
amount of protein was used (Additional file 3: Figure S2).
The interconversion of methylmalonyl-CoA into succinyl-
CoA, as illustrated in Figures 2B and Additional file 4: S3,Figure 2 Formation of succinyl-CoA according to protein amount or t
according to the amount of protein used in the assay after 30 min of incub
initial concentrations of AdoCbl and MMCoA were 200 μM and 400 μM res
protein at 37°C as a function of incubation time (expressed in minutes). Th
263 μM respectively. Tests were done twice at 5, 10 and 40 minutes, five ti
presented as the mean ± SE (Standard Error).followed a quadriphasic time course: an ascending phase
(0-20 min), a slow-down phase (20-25 min), a plateau (25-
30 min) and a decline (30-40 min). Hydrolysis or degrad-
ation of Coenzyme A (CoA) esters occurred during the
process and Additional file 4: Figure S3 also shows the free
CoA concentration. Both enzyme activity and hydrolysis de-
creased the amount of methylmalonyl-CoA during the time
of incubation. Between 25 and 30 minutes, the concentra-
tion of methylmalonyl-CoA did not change drastically and
was around 130 μM; accordingly, a reduction in the pro-
duction of succinyl-CoA was not due to a depletion of
methylmalonyl-CoA.
Specificity, recovery and analyte stability
Specificity of the method was assessed by comparison of
non-spiked samples with spiked ones. Both samples (non-
spiked and spiked) had the same amount of protein. There
was not any interfering peak from liver extract at theime of incubation. A) Rate of formation of succinyl-CoA per min
ation at 37°C. Each amount of protein was tested 4 times and the
pectively. B) Concentration of succinyl-CoA (μM) formed by 66 μg of
e initial concentration of AdoCbl and MMCoA were 200 μM and
mes at 0 minute and 8 times at 15, 20, 25 and 30 minutes. Values are
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succinyl-CoA. The best recovery rate was observed using
66 μg of protein (Table 2). Stability of liver extract was stud-
ied to define optimal conditions for the analysis. Storage
(frozen homogenate of fresh tissue or fresh homogenate of
tissue snapped in liquid nitrogen) and processing condi-
tions were studied. When homogenates were prepared
from nitrogen-snapped frozen liver pieces, concentrations
of the analyte were similar to those measured on homoge-
nates prepared using fresh tissue and frozen at −80°C. The
CV between the two types of homogenates was 8.21%. The
analyte was also stable in liver crude extract for three fro-
zen/thawed cycles when stored at −20°C and thawed to
room temperature (CV = 7.30%). The % differences be-
tween two consecutive days (day 1 vs day 2; day 2 vs day 3)
for fresh liver homogenates and homogenates of nitrogen-
snapped liver tissue were 6.3; 7.7% and 5.8; 11.6% respect-
ively. The inter-day CVs were 7.30 and 9.43%, respectively
for the two types of homogenates. The quality control inTable 2 Recovery and stability of succinyl-CoA according to s
Recovery
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The best recovery ratio was observed with 66 μg of protein. The results of storage
of protein over 30 min of incubation at 37°C in presence of 200 μM of AdoCbl and
(75 μM) were included as quality control.each run reveals that the system is reliable with an accuracy
of 88.76% (Table 2). As shown in Table 3, samples remained
stable for at least 45 hours at room temperature with CVs
varying from 4.55 to 9.22%. Similarly, when used three con-
secutive days, succinyl-CoA standard remained stable with
an accuracy varying from 85% to 104% (Table 3). Data in
Additional file 5: Table S2 strengthens the precision data of
the method with accuracies varying from 84% to 93% for
three control concentrations of methylmalonyl-CoA.
Pharmacokinetics
Figure 3 presents the velocity of MCM versus increasing
concentration of substrate after 30 minutes of incuba-
tion at 37°C. Apparent kinetic parameters for MCM
(Km and Vmax) were determined using 66 μg of protein
and 200 μM of AdoCbl, but increasing concentrations of
methylmalonyl-CoA (4.69-300 μM). Values for Vmax
(1.1544 μM per min) and Km (49.126 μM) were calcu-






Conc (μM) CV% CV% inter-day % difference
60.88 1.72 day 1 vs day 2: 7.7
56.20 0.90 day 2 vs day 3: 6.3
52.64 3.25 day 1 vs day 3: 13.5
7.30
58.72 5.05 day 1 vs day 2: 11.6
51.93 8.21 day 2 vs day 3: 5.8











stability correspond to the mean concentration of SSCoA (μM) formed by 66 μg
400 μM of MMCoA. Two vials of a known concentration of the standard
Table 3 Stability of succinyl-CoA after completion of experiences and quality control test with succinyl-CoA
standard solutions
Post-process stability
Sample ID Injection count Time after the first injection (hours) Mean concentration of SSCoA (μM) CV% inter-injection
Bovine-liver-1 2 33 33.74 9.22
Bovine-liver-2 2 39 65.59 7.25
Bovine-liver-3 2 40 56.11 6.67
Bovine-liver-4 2 45 51.20 4.55
Standard (SSCoA) High Qc Middle Qc Low Qc-2 Low Qc-1
Nominal value 500 μM 62.5 μM 7.8 μM 3.9 μM
day 1
485.14 59.99 7.11 3.53
415.51 63.46 7.12 3.98
414.23 51.80 10.20 4.29
Mean (n = 3) 438.29 58.42 8.15 3.93
CV% 9.26 10.25 21.87 9.67
day 2
441.52 67.30 7.86 3.75
435.70 56.49 7.97 3.72
433.57 56.71 7.86 3.51
Mean (n = 3) 436.93 60.16 7.90 3.66
CV% 0.94 10.27 0.83 3.61
day 3
401.95 64.41 8.39 3.52
405.45 64.14 8.48 3.67
403.39 62.29 8.53 3.48
Mean (n = 3) 403.60 63.61 8.47 3.56
CV% 0.44 1.82 0.86 2.79
CV% inter-days (n = 9) 6.23 8.08 11.33 7.20
Accuracy% 85.25 97.17 104.75 95.29
The post-process stability study used 66 μg of protein over 30 min of incubation at 37°C in presence of 200 μM of AdoCbl and 400 μM of MMCoA. The quality
control (Qc) study used four concentrations of the standard succinyl-CoA. The calculated accuracies varied from 85% to 104%.
Figure 3 Velocity of MCM versus increasing concentration of substrate after 30 min of incubation at 37°C. The results are based on the
mean concentration of succinyl-CoA (SCCoA) for 2 assays; we tested 7 substrate (methylmalonyl-CoA, MMCoA) concentrations (4.69-300 μM)
using 66 μg of protein and 200 μM of AdoCbl. Each concentration level was duplicated in each assay. Error bars are the Standard Error (SE).
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Table 5 Specific activity of MCM measured in liver of
dairy cows at their peak of lactation
Dairy cows Total SA ± SD (n = 3)
nmole/min/mg
CV% Holo SA ± SD (n = 3)
nmole/min/mg
CV%
1 15.249 ± 0.543 3.56 0.467 ± 0.035 7.57
2 12.027 ± 0.973 8.09 0.561 ± 0.036 6.37
3 15.415 ± 0.631 4.10 0.489 ± 0.012 2.46
4 13.091 ± 0.397 3.03 0.513 ± 0.046 8.88
5 14.552 ± 0.881 6.05 0.352 ± 0.002 4.65
6 12.714 ± 0.405 3.18 0.676 ± 0.014 2.09
Assays were performed in presence of 200 μM of AdoCbl and 400 μM of
MMCoA. Incubation was conducted at 37°C for 30 min. The amounts of
protein used in the assays were 40 μg. Specific activities (SA) are expressed as
nmoles of succinyl-CoA/min/mg protein. Standard deviation (SD) and
coefficients of variation (CV%) are also presented.
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When reported per mg of protein, Vmax was 17.5 μM of
succinyl-CoA per minute per milligram of protein or
3.5 nmol/min/mg protein if the volume (200 μL) of reac-
tion medium is taken into account. Mean specific activity
of MCM in a bovine liver obtained from a slaughterhouse
was 5.9 ± 0.4 nmol/min/mg protein (Table 4).
The holomutase specific activity in liver of six lactating
dairy cows at the same stage of lactation and fed the
same diet represented between 2 and 5% of the total activ-
ity, it varied from 0.352 ± 0.002 to 0.68 ± 0.01 nmol/min/
mg protein whereas the total specific activity varied from
12 ± 1 to 15.4 ± 0.6 nmol/min/mg protein (Table 5).
Discussion
Several methods for measuring MCM activity have been
published. Some of these methods used radioactive iso-
topes [9-17], others are not [8,18-22]. Among these latter
methods, evidence suggests that HPLC is more reprodu-
cible and accurate for measurement of small amounts of
succinyl-CoA [29]. Validated data for the RP-HPLC ac-
cording to criteria from FDA guidelines for bioanalytical
method validation [32] are provided.
Bovine liver was chosen because of the importance
of gluconeogenesis for ruminant animal, one of the
major substrate being propionate [33]. A series of studies
were performed to investigate the interconversion of
methylmalonyl-CoA into succinyl-CoA in this tissue. As
can be seen from this study, the amounts of succinyl-CoA
formed increased with time until 20 minutes of incubation
and the reaction is completed after half-hour of incu-
bation. Conversion of methylmalonyl-CoA into succinyl-
CoA also increased when increasing the amount of
protein until 208 μg. It was also observed that reactionTable 4 Specific activity of MCM measured in liver
obtained from slaughterhouse






Run 1 5.563 ± 0.200 3.60
Run 2 6.569 ± 0.333 5.07
Run 3 6.015 ± 0.281 4.68
Run 4 6.465 ± 0.378 5.85
Run 5 6.234 ± 0.502 8.05
Run 6 5.558 ± 0.166 2.98
Run 7 6.150 ± 0.106 1.72
Run 8 5.677 ± 0.051 0.90
Run 9 5.317 ± 0.173 3.25
Mean SA 5.950 ± 0.44 7.40
Assays were performed in presence of 200 μM of AdoCbl and 400 μM of
MMCoA. Incubation was conducted at 37°C for 30 min. The amounts of
protein used in the assays were 66 μg. Specific activities (SA) are expressed as
nmoles of succinyl-CoA/min/mg protein. Standard deviation (SD) and
coefficients of variation (CV%) are also presented.rates increased with increasing amounts of substrate.
The method is specific; its reproducibility depends on
the initial concentrations of the enzyme in the studied
tissue. The reproducibility of the method published by
Gaire and colleagues was greatly improved by bringing
the inter-day CV from 12.16% [29] to 7.30% (present study).
After completion of experiences, analyte remained stable
and an analytical run could be reanalyzed in the case of
instrument failure.
Analytes were considered stable in mouse [34] and hu-
man [35] plasma when the difference of concentration
was less than 15% between freshly prepared samples and
samples tested under various conditions [34,35]. In the
present study, difference between fresh homogenates
prepared from liver biopsies snapped in liquid nitrogen
and frozen homogenates prepared from fresh tissue (6%)
was inferior to 15%. Similarly, after 3 frozen/thawed
cycles, this difference was low for two consecutive days.
Accordingly, present results suggested that the analytes
are stable during sample storage, extraction and chroma-
tography processes for MCM in liver samples. However
repeated frozen/thawed cycles of homogenates should
be avoided because in spite of low CV, the average con-
centration numerically decreased from day 1 to day 3.
The estimated Km of the enzyme MCM calculated in
the present study is lower than in previous reports. Willard
and Rosenberg measured a Km value of 70 μM for the
crude human MCM in fibroblast extracts [36]. A compar-
able Km (60 μM) has been measured by Taoka and co-
workers with human recombinant MCM [7]. Higher
values have been reported for human (300 to 350 μM) and
mouse hepatic MCM (270 μM) using a radiolabeled meth-
odology [37,38]. To determine MCM activity, Taoka et al.
used the spectrophotometric detection of the CoA
resulting from the hydrolysis of the succinyl-CoA. Results
from the present study are lower than the mean Km value
previously reported by our team (160 μM) in liver of lactat-
ing dairy cows [8], using the spectrometric assay method
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http://www.biomedcentral.com/1471-2091/14/25described by Taoka et al. [7]. Using a HPLC method, Gaire
et al. measured a total specific activity of hepatic MCM in
rat of 6.15 nmol/min/mg protein [29] whereas the radio-
metric method gave a value of 1.9 nmol/min/mg protein
for the same sample [29]. The discrepancies observed may
not only be species-dependent, especially ruminant versus
non-ruminant, but also due to the method limitations.
Total specific activity in liver of dairy cows previ-
ously reported [8] using mitochondrial extract aver-
aged 10.8 nmol/min/mg protein and was in the same
range than the present data for lactating dairy cows.
Total specific activity of MCM in a liver obtained from a
slaughterhouse (5.95 nmol/min/mg protein) was similar
to published values obtained in rat [29,30], mouse [38]
and sheep [23] livers.
In ruminants, methylmalonyl-CoA is involved in
gluconeogenesis [27]. Propionate is the major substrate
for gluconeogenesis in dairy cows [6], and MCM is a key
enzyme in the metabolism of propionate [39], essential to
its entry into Krebs cycle and subsequent gluconeogenesis.
Amongst all ruminants, efficient gluconeogenesis is most
important in high-producing dairy cows because it is the
major pathway for maintaining adequate glucose supply
to the mammary gland for milk production [40]. In the
present study, it was not known whether the liver bought
from a slaughterhouse was from a steer, a heifer or a lactat-
ing or dry cow. Therefore, differences observed in specific
activities between the liver obtained from the slaughter-
house and liver tissues obtained from lactating dairy cows
at their peak of lactation are likely due to the physiological
stage of the animal. Nevertheless, it cannot be ruled out
that difference in the mode of preparation (treated within
less than 1 hour after slaughter or frozen immediately after
biopsy) could affect MCM activity measurements.
Conclusions
Recently, a capillary electrophoresis method to measure
MCM activity has been published [30]. We took an inter-
est in that method for its short elution time (10 min) but
the separation buffer needed 15 mM of sodium dodecyl
sulfate (SDS) [30]. SDS is a highly effective surfactant [41].
In routine applications, dedication of one capillary to each
application (particularly if surfactants are present) is re-
commended [42]. Furthermore, the high-concentration
surfactant decreases both the separation efficiency and the
reproducibility of the electrophoretic capillary method
[31]. Indeed, as regards the signal-to-noise ratio of 3, the
authors had a LOD of 3.4 μM [30] suggesting that present
RP-HPLC is more sensitive with a LOD of 1 μM for the
succinyl-CoA. As described in the materiel and method
section, a centrifugation step after protein precipitation
using TCA improved repeatability as compared to previ-
ous published results [29]. In addition, 100 mM of acetic
acid in mobile phase improved the separation of residualsubstrate (methylmalonyl-CoA) and product (succinyl-
CoA), and consequently contributed to improve system
suitability. Finally the method is specific, accurate, precise
and more sensitive than the previously published ones for
the quantitative determination of methylmalonyl-CoA and
succinyl-CoA in liver. It can be easily implemented into
routine practice. This comprehensively validated method
will allow studying the effects of stages of lactation, diet
composition, and physiology in cattle. It is ideal for ana-
lysis of MCM activity and hence a tool to monitor cobala-
min status in experimental and clinical studies.
Additional files
Additional file 1: Figure S1. Calibration curve of methylmalonyl-CoA.
The linearity range was 3.9 to 500 μM. Area under of the curve (AUC) is
presented as a function of methylmalonyl-CoA concentration (MMCoA
Conc) expressed in μM.
Additional file 2: Table S1. System suitability parameters. Values in the
results column are calculated according to Figure 1. t1 = retention time
of the peak of methylmalonyl-CoA. t2: retention time of the peak of
succinyl-CoA. w1 =Width at half height for the peak of methylmalonyl-
CoA. w2: width at half for the peak of succinyl-CoA. L: length of the column
in centimetres. t0: time of unretained peak. tL: retention time of leading
edge at 5% height. tT: retention time of tailing edge at 5% height.
Additional file 3: Figure S2. Velocity for increasing amounts of protein
after 30 minutes of incubation at 37°C. Concentration of succinyl-CoA
formed (μM) per min according to the quantity of protein used in the
assay (0 – 333 μg) in presence of 200 μM of AdoCbl and 400 μM
methylmalonyl-CoA.
Additional file 4: Figure S3. Changes in coenzyme A, succinyl-CoA and
methylmalonyl-CoA concentrations according to incubation time. The
results are mean concentrations of CoA (Coenzyme A), SSCoA (succinyl-
CoA) and MMCoA (methylmalonyl-CoA) for 66 μg of protein incubated at
37°C. The initial concentration of AdoCbl and MMCoA were 200 μM and
263 μM respectively. Tests were done twice at 5, 10 and 40 minutes, five
times at 0 minute and 8 times at 15, 20, 25 and 30 minutes. Inserted
graph emphasizes the pattern of SSCoA.
Additional file 5: Table S2. Stability of three concentrations of
standard solutions of methylmalonyl-CoA. The quality control (Qc) study
used three concentrations of the methylmalonyl-CoA measured in two
assays during three consecutive days. The calculated accuracies varied
from 84% to 93%.
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